Dr. Margaret Ilomuanya and Dr. Mutiat Bolanle Ibrahim Dr. Margaret Ilomuanya and Dr. Mutiat Bolanle Ibrahim, both of whom are experts in their respective fields, received grants worth over US$600,000 in total for their innovative proposals that aim to address some of the pressing challenges in health and agriculture in Africa.
Dr. Ilomuanya, of the Department of Pharmaceutics and Pharmaceutical Technology, won a grant of US$359,100 for her research titled “The Cervical Mucus Barrier as a Target for Artificial Neural Network Inspired Novel Blends of Electrospun Scaffolds”.
The project seeks to develop a novel contraceptive device that can prevent unwanted pregnancies and sexually transmitted infections by mimicking the natural cervical mucus barrier.
Dr. Ibrahim, of the Department of Pharmacognosy, won a grant of US$259,801.30 for her research titled: “Characterisation of Herbal Bioactive for the Development of Spermicides for Female Contraception”. The project aims to identify and characterize herbal compounds that can act as spermicides and provide a safe, effective, and affordable alternative to conventional contraceptives.
The two dons were among the 11 African researchers who were announced on Monday, February 12, 2024, as recipients of the key grants under the GC Africa initiative, a flagship program of the Science for Africa Foundation with support from the Bill and Melinda Gates Foundation. The grants are designed to propel innovative research in climate adaptation for agriculture and the development of safer, easier-to-access, and use contraceptives.
The GC Africa initiative seeks to promote Africa-led scientific innovations to help countries better achieve the Sustainable Development Goals by awarding seed and scale-up grants to the continent’s most impressive solutions. GC Africa supports big, bold impactful innovative ideas that have a potential for impact, scale, and sustainability.
Category: World-News
Tag: Two Nigerian Lecturers Win N900 Million to Research on Key Innovations
Written by Author (author)
Published 2/17/2024 6:19:59 PM